Ruth Bader Ginsburg being treated for cancer, says she won’t retire

The 87-year-old Supreme Court justice says treatment so far has succeeded in reducing lesions on her liver

Justice Ruth Bader Ginsburg Speaks At Georgetown Law
U.S. Supreme Court Justice Ruth Bader Ginsburg participates in a discussion at the Georgetown University Law Center on February 10, 2020 in Washington, DC. (Photo by Sarah Silbiger/Getty Images)

WASHINGTON (AP) — Justice Ruth Bader Ginsburg said Friday she is receiving chemotherapy for a recurrence of cancer, but has no plans to retire from the Supreme Court.

The 87-year-old Ginsburg, who spent time in the hospital this week for a possible infection, said her treatment so far has succeeded in reducing lesions on her liver and that she will continue chemotherapy sessions every two weeks.

Read More: Supreme Court says Justice Ruth Bader Ginsburg hospitalized with infection

Ruth Bader Ginsburg thegrio.com
Associate Justice of the Supreme Court of the United States Ruth Bader Ginsburg speaks during the Cinema Cafe with Justice Ruth Bader Ginsburg and Nina Totenberg during the 2018 Sundance Film Festival at Filmmaker Lodge on January 21, 2018 in Park City, Utah. (Photo by Robin Marchant/Getty Images)

Read More: Woman vice president, Supreme Court justice is welcomed — but don’t hold your breath

“I have often said I would remain a member of the Court as long as I can do the job full steam. I remain fully able to do that,” Ginsburg said in a statement issued by the court.

She said her recent hospitalizations, including one in May, were unrelated to the cancer.

A medical scan in February revealed growths on her liver, she said, and she began chemotherapy in May.

“My most recent scan on July 7 indicated significant reduction of the liver lesions and no new disease,” she said. “I am tolerating chemotherapy well and am encouraged by the success of my current treatment.”

Have you subscribed to theGrio’s new podcast “Dear Culture”? Download our newest episodes now!

Mentioned in this article:

More About: